Schedule 13G ownership disclosure

NEUROONE MED TECHNOLOGIES CO

Common Stock, $0.001 par value · CUSIP: 64130M209

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MANCHESTER EXPLORER, L.P.

    Shares: 1,333,333.00 · Class: 4.1%

  • MANCHESTER MANAGEMENT COMPANY, LLC

    Shares: 1,499,999.00 · Class: 4.6%

  • MANCHESTER MANAGEMENT PR, LLC

    Shares: 1,499,999.00 · Class: 4.6%

  • JAMES E. BESSER

    Shares: 1,583,332.00 · Class: 4.9%

  • MORGAN C. FRANK

    Shares: 1,416,666.00 · Class: 4.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-001497
Form type
SCHEDULE 13G/A
Filer
MANCHESTER MANAGEMENT CO LLC
CIK
CIK 1169253
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub